Latest News & Updates
Breaking News
26 minutes ago
Vaibhavi M.
20260225154539.png)
Other trending news you may like to read
The United Laboratories International Holdings Limited (TUL) And Novo Nordisk Report Positive Phase 2 Data For UBT251 Triple Agonist In Obesity
TUL and Novo Nordisk report 19.7% weight loss in Phase 2 trial of UBT251 triple agonist for obesity.
Vaibhavi M.
European Medicines Agency Authorizes Oryzon’s Phase II IDEAL Trial Of Iadademstat In Essential Thrombocythemia
EMA authorizes Oryzon’s Phase II IDEAL trial of iadademstat in essential thrombocythemia.
Vaibhavi M.
Kyverna Therapeutics Inc. Strengthens Board With The Addition Of Sravan K. Emany And Andrew Miller, Ph.D., Marking A Key Transition In Its Autoimmune CAR T Growth Strategy
Kyverna Therapeutics appoints Sravan Emany and Andrew Miller to strengthen its autoimmune CAR T strategy.
Simantini Singh Deo
20260225145316.png)
Cosmos Health Inc. Appoints Dimitrios Iliopoulos To Its Advisory Board To Advance AI-Powered Drug Discovery And Clinical-Stage Biotechnology Strategy
Cosmos Health Inc. appoints AI drug-discovery expert Dimitrios Iliopoulos to strengthen biotech strategy.
Simantini Singh Deo
